Janssen Inc. v. Apotex Inc.
The Court held Janssen's proposed blanket variance was overly broad and that documents not tendered in open court remain subject to the implied undertaking, requiring Janssen to seek relief; nevertheless the Court granted a limited variance permitting Janssen to use specified 'Conceded Evidence' from the within...
Source-derived case information.
- Citation
- 2022 FC 1746
- Parties
- Plaintiff: JANSSEN INC.; Plaintiff: JANSSEN PHARMACEUTICA N.V.; Defendant: APOTEX INC.
- Court
- Federal Court
- Jurisdiction
- Canada
- Judgment Date
- 20 December 2022
- Procedural Posture
- Patent Infringement (patented Medicines (notice of Compliance) Regulations) and Motion to Vary Protective Order / Motion to Vary Protective and Confidentiality Order Under Rule 151; Related Summary Judgment Motions Pending in New Actions
- Outcome
- Motion granted in part; Confidentiality Order varied to permit use of specified evidence in Court files T-1121-22, T-1122-22, T-1248-22 and T-1249-22; no costs awarded.
- Legal Topics
- Implied Undertaking, Variation of Protective Order, Res Judicata, Abuse of Process, Notice of Allegation (noc) Proceedings
- Source Language
- english
Source-derived case record
Summary, issues, holding and outcome
More case intelligence is available
Unlock the full research layer for this judgment.
Parties
JANSSEN INC.
Plaintiff
JANSSEN PHARMACEUTICA N.V.
Plaintiff
APOTEX INC.
Defendant
Procedural Posture
Patent Infringement (patented Medicines (notice of Compliance) Regulations) and Motion to Vary Protective Order / Motion to Vary Protective and Confidentiality Order Under Rule 151; Related Summary Judgment Motions Pending in New Actions
Legal Issues
- 1 Whether the motion is procedurally defective for failure to seek relief from the implied undertaking
- 2 Whether the proposed variation of the Confidentiality Order is overly broad
Ratio Decidendi
The Court held Janssen's proposed blanket variance was overly broad and that documents not tendered in open court remain subject to the implied undertaking, requiring Janssen to seek relief; nevertheless the Court granted a limited variance permitting Janssen to use specified 'Conceded Evidence' from the within action in four identified related actions to support res judicata/abuse of process claims and awarded no costs.
Court Disposition
Motion granted in part; Confidentiality Order varied to permit use of specified evidence in Court files T-1121-22, T-1122-22, T-1248-22 and T-1249-22; no costs awarded.
Orders
- The Protective and Confidentiality Order of March 22, 2021 is varied to allow use of the following evidence in Court actions T-1121-22, T-1122-22, T-1248-22 and T-1249-22: paragraphs 1-5, 21, 23, 26, 53-57, 60-62, 64, 69-70, 76-81 and 83-89 of Apotex’s Summary Trial Memorandum of Fact and Law; paragraphs 12-13 and...
- No costs are awarded.
Full Case Text
Judgment text and source record
Sign in to read
Sign in to read the full judgment text
Sign in to read the full judgment text. Downloads and additional research tools may depend on your plan.
Sign in to read the full judgment